Life Science Software Market Introduction and Overview
According to SPER Market Research, the Global Life Science Software Market is estimated to reach USD 64.71 billion by 2033 with a CAGR of 13.11%.
The report includes an in-depth analysis of the Global Life Science Software Market, including market size and trends, product mix, Applications, and supplier analysis. Life science software consists of standardized workflow and document management tools for the biopharmaceutical, medical technology, generics, and clinical care industries. This software enables businesses to securely record, store, and retain data in the form of photos and texts. This software converts the data into an electronic format, allowing healthcare practitioners to quickly access it and gain valuable insights. Life science software applications include drug identification and validation, laboratory management, clinical trial administration, and medical device invention.
- 2021: Kathy VanEnkevort is the new General Manager of Microsoft's Health and Life Sciences Industry team.
- 2021: IQVIA purchased Myriad Genetics' rival division. This division, known as Myriad RBM, is expected to be integrated into IQVIA's Q2 Solutions. Myriad RBM offers contract research services to the pharmaceutical industry, such as screening diseased and non-disease clinical samples against the company's menu of biomarkers.
Market Opportunities and Challenges
Opportunities- The market for life science software is growing due to a number of factors, including ongoing technological advancements, the availability of big data in the life science sector, the growing use of analytics techniques for pharmaceutical company sales and marketing, clinic and hospital operations, and the growing demand for improved patient care. In addition, the market has grown significantly due to a number of factors, including a rise in the prevalence of chronic diseases, intense pressure to cut healthcare costs, and increased emphasis on value-based medicine.
Challenges- Strict regulatory requirements, which differ greatly between regions, apply to the life science industry. It takes money and effort to meet these compliance standards. Removing this restriction necessitates ongoing investments in software development and regulatory knowledge to guarantee compliance, which can be difficult for smaller software providers. Furthermore, strict data security protocols are required when handling private health information and sensitive patient data. Trust and reputation can be severely harmed by data breaches and privacy issues. Sustaining cybersecurity investments and adhering to evolving data protection regulations are necessary to address these concerns.
Market Competitive Landscape
To boost sales and obtain a competitive edge in the global life science software market, these major life science software providers are implementing a variety of strategies, including partnerships, collaborations, acquisitions, mergers, and the introduction and approval of new products. Some of the key players are – Allscripts Healthcare LLC ,Cerner Corporation ,Cognizant ,CPSI ,Elinext ,EPIC Systems Corporation , INFOR ,Jag products LLC ,Meta and Oracle
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Type, By Application, By Component, By Solution
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
|
| Companies Covered | Allscripts Healthcare LLC, Cerner Corporation , Cognizant, CPSI , Elinext , EPIC Systems Corporation, INFOR, Jag products LLC ,Meta, Oracle
|
COVID-19 Impact on Global Life Science Software Market
The global market for life science software has experienced significant effects due to the COVID-19 pandemic. The need for software solutions assisting with drug discovery, genomics, and clinical trials has surged due to the urgency of creating remedies and vaccines for the virus. The ban on in-person meetings made remote work and collaboration tools necessary, which hastened the uptake of cloud-based platforms and online collaboration tools. Disruptions in the supply chain, however, made it more difficult for businesses to obtain the software licenses and hardware parts they needed.
Key Target Audience:
- Academic and Research Institutions
- Biotechnology Companies
- Clinical Research Organizations (CROs)
- Medical Device Manufacturers
- Venture Capitalists and Investors
- Others
Our in-depth analysis of the Life Science Software Market includes the following segments:
|
By Type:
|
Descriptive
Predictive
Prescriptive
|
|
By Application:
|
Compliance
Marketing
R &D
Pharmacovigilance
SCM
|
|
By Component:
|
Software
Services
|
|
By Solution:
|
Cloud- Based
On- Premises
|
Key Topics Covered in the Report:
- Global Life Science Software Market Size (FY’2024-FY’2033)
- Overview of Global Life Science Software Market
- Segmentation of Global Life Science Software Market By Type (Descriptive, Predictive and Prescriptive.)
- Segmentation of Global Life Science Software Market By Application (Compliance, Marketing, R & D, Pharmacovigilance and SCM.)
- Segmentation of Global Life Science Software Market By Component (Software and Services.)
- Segmentation of Global Life Science Software Market By Solutions (Cloud- Based and On- Premises.)
- Statistical Snap of Global Life Science Software Market
- Expansion Analysis of Global Life Science Software Market
- Problems and Obstacles in Global Life Science Software Market
- Competitive Landscape in the Global Life Science Software Market
- Impact of COVID-19 and Demonetization on Global Life Science Software Market
- Details on Current Investment in Global Life Science Software Market
- Competitive Analysis of Global Life Science Software Market
- Prominent Players in the Global Life Science Software Market
- SWOT Analysis of Global Life Science Software Market
- Global Life Science Software Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Life Science Software Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Life Science Software Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Life Science Software Market
7. Global Life Science Software Market, By Type (USD Million)
7.1. Global Life Science Software Market Value Share and Forecast, By Type, 2024-2033
7.2. Descriptive
7.3. Predictive
7.4. Prescriptive
8. Global Life Science Software Market, By Application (USD Million)
8.1. Global Life Science Software Market Value Share and Forecast, By Application, 2024-2033
8.2. Compliance
8.3. Marketing
8.4. R &D
8.5. Pharmacovigilance
8.6. SCM
9. Global Life Science Software Market, By Component (USD Million)
9.1. Global Life Science Software Market Value Share and Forecast, By Component, 2024-2033
9.2. Software
9.3. Services
10. Global Life Science Software Market, By Solution (USD Million)
10.1. Global Life Science Software Market Value Share and Forecast, By Solution, 2024-2033
10.2. Cloud- Based
10.3. On- Premises
11. Global Life Science Software Market Forecast, 2020-2033 (USD Million)
11.1. Global Life Science Software Market Size and Market Share
12. Global Life Science Software Market, By Type, 2020-2033 (USD Million)
12.1. Global Life Science Software Market Size and Market Share By Type (2020-2026)
12.2. Global Life Science Software Market Size and Market Share By Type (2027-2033)
13. Global Life Science Software Market, By Application, 2020-2033 (USD Million)
13.1. Global Life Science Software Market Size and Market Share By Application (2020-2026)
13.2. Global Life Science Software Market Size and Market Share By Application (2027-2033)
14. Global Life Science Software Market, By Component, 2020-2033 (USD Million)
14.1. Global Life Science Software Market Size and Market Share By Component (2020-2026)
14.2. Global Life Science Software Market Size and Market Share By Component (2027-2033)
15. Global Life Science Software Market, By Solution, 2020-2033 (USD Million)
15.1. Global Life Science Software Market Size and Market Share By Solution (2020-2026)
15.2. Global Life Science Software Market Size and Market Share By Solution (2027-2033)
16. Global Life Science Software Market, By Region, 2020-2033 (USD Million)
16.1. Global Life Science Software Market Size and Market Share By Region (2020-2026)
16.2. Global Life Science Software Market Size and Market Share By Region (2027-2033)
16.3. Asia-Pacific
16.3.1. Australia
16.3.2. China
16.3.3. India
16.3.4. Japan
16.3.5. South Korea
16.3.6. Rest of Asia-Pacific
16.4. Europe
16.4.1. France
16.4.2. Germany
16.4.3. Italy
16.4.4. Spain
16.4.5. United Kingdom
16.4.6. Rest of Europe
16.5. Middle East and Africa
16.5.1. Kingdom of Saudi Arabia
16.5.2. United Arab Emirates
16.5.3. Rest of Middle East & Africa
16.6. North America
16.6.1. Canada
16.6.2. Mexico
16.6.3. United States
16.7. Latin America
16.7.1. Argentina
16.7.2. Brazil
16.7.3. Rest of Latin America
17. Company Profile
17.1. Allscripts Healthcare LLC
17.1.1. Company details
17.1.2. Financial outlook
17.1.3. Product summary
17.1.4. Recent developments
17.2. Cerner Corporation
17.2.1. Company details
17.2.2. Financial outlook
17.2.3. Product summary
17.2.4. Recent developments
17.3. Cognizant
17.3.1. Company details
17.3.2. Financial outlook
17.3.3. Product summary
17.3.4. Recent developments
17.4. CPSI
17.4.1. Company details
17.4.2. Financial outlook
17.4.3. Product summary
17.4.4. Recent developments
17.5. Elinext
17.5.1. Company details
17.5.2. Financial outlook
17.5.3. Product summary
17.5.4. Recent developments
17.6. EPIC System Corporation
17.6.1. Company details
17.6.2. Financial outlook
17.6.3. Product summary
17.6.4. Recent developments
17.7. INFOR
17.7.1. Company details
17.7.2. Financial outlook
17.7.3. Product summary
17.7.4. Recent developments
17.8. Jag Products LLC
17.8.1. Company details
17.8.2. Financial outlook
17.8.3. Product summary
17.8.4. Recent developments
17.9. Meta
17.9.1. Company details
17.9.2. Financial outlook
17.9.3. Product summary
17.9.4. Recent developments
17.10. Oracle
17.10.1. Company details
17.10.2. Financial outlook
17.10.3. Product summary
17.10.4. Recent developments
17.11. Others
18. List of Abbreviations
19. Reference Links
20. Conclusion
21. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
